等待開盤
0.000
NaN.00%
Mr. Bonney brings more than three decades of leadership experience in the biopharmaceutical industry, including significant expertise in multiple sclerosis (MS) and broader central nervous system markets. Notably, during
05-19 18:32
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more t...
2025-03-11 21:56